Table 1.
Demographic and clinical data of the study patients (n = 100)
Parameter | No erythromycin | Erythromycin | P |
(n = 50) | (n = 50) | ||
Age, yr (mean ± SD) | 51.7 ± 21.6 | 52.1 ± 19.4 | 0.931 |
Male/Female | 32/18 | 36/14 | 0.39 |
Indications | 0.40 | ||
Suspected Crohn’s | 19 | 18 | 0.84 |
Obscure GI bleeding | 23 | 28 | 0.32 |
Others2 | 8 | 4 | 0.22 |
Final diagnosis in SB | 0.10 | ||
Normal findings | 23 | 19 | 0.42 |
Non-specific findings | 9 | 7 | 0.59 |
Crohn’s disease | 1 | 7 | 0.06 |
Angiodysplasia | 7 | 2 | 0.16 |
Polyps | 1 | 3 | 0.62 |
Others2 | 9 | 12 | 0.46 |
Unpaired t-test;
Includes Indication (abdominal pain, celiac and polyposis syndrome) and final diagnosis (nodular hyperplasia, edematous fold, etc); the rest of P values are according to nonparametric Mann-Whitney test. SB: Small bowel; GI: Gastrointestinal.